Tofacitinib Tablet, Film Coated, Extended Release
Product Images NDC 70771-1627

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tofacitinib (NDC 70771-1627). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

11 mg (7e9346bb C19d 43dc 90dd 6a99ad184add 01)

Label for tofacitinib extended-release tablets, 11 mg strength, film coated oral tablets. The label states it contains 30 tablets for prescription use only. The labeler is Zydus Lifesciences Limited, and it includes storage instructions, child-resistant packaging notice, and pharmacist dispensing guidance. Manufacturer is Cadila Healthcare Ltd., Ahmedabad, India.*

FDA Label Image

22 mg (7e9346bb C19d 43dc 90dd 6a99ad184add 02)

Label for tofacitinib extended-release tablets, 22 mg strength, film-coated, oral dosage form. The label features the proprietary name 'Tofacitinib Extended-Release Tablets' prominently with a yellow box highlighting '22 mg.' It indicates a package size of 30 tablets and states 'Rx only.' The label includes storage instructions, a pharmacist dispensing note, and manufacturer information: Cadila Healthcare Ltd., Ahmedabad, India. The NDC number 70771-1628-3 and a barcode are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.